These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12131563)
1. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. Cherry CL; Gahan ME; McArthur JC; Lewin SR; Hoy JF; Wesselingh SL J Acquir Immune Defic Syndr; 2002 Jul; 30(3):271-7. PubMed ID: 12131563 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. van der Valk M; Casula M; Weverlingz GJ; van Kuijk K; van Eck-Smit B; Hulsebosch HJ; Nieuwkerk P; van Eeden A; Brinkman K; Lange J; de Ronde A; Reiss P Antivir Ther; 2004 Jun; 9(3):385-93. PubMed ID: 15259901 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of human mitochondrial DNA using a real-time PCR assay. Gourlain K; Amellal B; Ait Arkoub Z; Dupin N; Katlama C; Calvez V HIV Med; 2003 Jul; 4(3):287-92. PubMed ID: 12859329 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy. Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition. Casula M; van der Valk M; Wit FW; Nievaard MA; Reiss P HIV Med; 2007 Jan; 8(1):32-7. PubMed ID: 17305930 [TBL] [Abstract][Full Text] [Related]
7. Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals. Cherry CL; Nolan D; James IR; McKinnon EJ; Mallal SA; Gahan ME; Lal L; McArthur JC; Wesselingh SL J Acquir Immune Defic Syndr; 2006 Aug; 42(4):435-40. PubMed ID: 16810110 [TBL] [Abstract][Full Text] [Related]
8. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients. Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702 [TBL] [Abstract][Full Text] [Related]
10. Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. Gahan ME; Miller F; Lewin SR; Cherry CL; Hoy JF; Mijch A; Rosenfeldt F; Wesselingh SL J Clin Virol; 2001 Oct; 22(3):241-7. PubMed ID: 11564588 [TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688 [TBL] [Abstract][Full Text] [Related]
12. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983 [TBL] [Abstract][Full Text] [Related]
13. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients. Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293 [TBL] [Abstract][Full Text] [Related]
14. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM; Antivir Ther; 2007; 12(2):205-16. PubMed ID: 17503663 [TBL] [Abstract][Full Text] [Related]
15. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors. Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163 [TBL] [Abstract][Full Text] [Related]
16. Evidence of nucleoside analogue reverse transcriptase inhibitor--associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients. Walker UA; Bickel M; Lütke Volksbeck SI; Ketelsen UP; Schöfer H; Setzer B; Venhoff N; Rickerts V; Staszewski S J Acquir Immune Defic Syndr; 2002 Feb; 29(2):117-21. PubMed ID: 11832679 [TBL] [Abstract][Full Text] [Related]
17. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156 [TBL] [Abstract][Full Text] [Related]
18. Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy. Timmermans EC; Tebas P; Ruiter JP; Wanders RJ; de Ronde A; de Baar MP Clin Chem; 2006 Jun; 52(6):979-87. PubMed ID: 16601068 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554 [TBL] [Abstract][Full Text] [Related]
20. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Nolan D; Hammond E; James I; McKinnon E; Mallal S Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]